Batavia Biosciences receives $2.2 million follow-up grant from PATH to support new tools for polio eradication era
July 08, 2019 07:00 ET | Batavia Biosciences B.V.
Leiden, 4 Jul 2019 – Today, Batavia Biosciences announces it received a follow-up grant of $2.2 million from PATH – a global organization dedicated to health equity – to develop and manufacture novel...
Batavia Biosciences Receives $13.2M Grant to Accelerate Market Access of Low-Cost Inactivated Polio Vaccine
February 25, 2019 05:00 ET | Batavia Biosciences B.V.
Leiden, The Netherlands, February 25, 2019 – Batavia Biosciences announced today that it received a $13.2 million grant from the Bill & Melinda Gates Foundation to manufacture clinical-grade...